Recruiting PHASE4 INTERVENTIONAL 2-arm
NCT07183462
Azithromycin and Ampicillin for Late PPROM (ALPRO)
Sponsor: Sheba Medical Center
Conditions
Antibiotic Prophylaxis Latency Period Neonatal Diseases and Abnormalities Pregnancy Complications, Infectious Premature Birth Prematurity
Interventions
Ampicillin/Amoxicillin plus single-dose PO Azithromycin Intravenous Ampicillin followed by Oral Amoxicillin
Updated 2 times since 2025 Last updated: Dec 10, 2025 Started: Sep 10, 2025 Primary completion: Jun 30, 2029 Completion: Jul 31, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE4 clinical study on Antibiotic Prophylaxis and Latency Period, this trial is actively recruiting participants. The trial is conducted by Sheba Medical Center and has accumulated 2 data snapshots since 2025. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
2 versions recorded-
Jan 2026 — Present [monthly]
Recruiting PHASE4
Status: Not Yet Recruiting → Recruiting
-
Oct 2025 — Jan 2026 [monthly]
Not Yet Recruiting PHASE4
First recorded
Sep 2025
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Sheba Medical Center
Data source: Sheba Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .